No difference in survival between laparoscopic surgery and open surgery in colorectal cancer patients with liver metastases

Bookmark and Share
Published: 3 Jun 2019
Views: 291
Dr Åsmund Fretland - Oslo University Hospital, Oslo, Norway

Dr Åsmund Fretland presents results at the 2019 American Society of Clinical Oncology (ASCO) Annual Meeting from the OSLO-COMET trial.

This was a randomised trial in which colorectal cancer patients with liver metastases were randomly assigned to either laparoscopic surgery or open surgery.

It was found that using laparoscopic surgery did not reduce chances of survival, with patients living a median 80 months after surgery compared with 81 months for patients who underwent open surgery.

Watch the interview here.